Kymera Therapeutics, Inc. (KYMR)
126.72
+5.67
(+4.68%)
USD |
NASDAQ |
Aug 25, 16:00
126.70
-0.02
(-0.02%)
After-Hours: 19:59
Kymera Therapeutics Total Return Level : 121.05 for Aug. 24, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| August 24, 2026 | 121.05 |
| August 21, 2026 | 119.80 |
| August 20, 2026 | 121.50 |
| August 19, 2026 | 127.31 |
| August 18, 2026 | 121.38 |
| August 17, 2026 | 121.41 |
| August 14, 2026 | 117.39 |
| August 13, 2026 | 114.42 |
| August 12, 2026 | 114.03 |
| August 11, 2026 | 109.62 |
| August 10, 2026 | 108.58 |
| August 07, 2026 | 107.52 |
| August 06, 2026 | 106.41 |
| August 05, 2026 | 105.48 |
| August 04, 2026 | 104.39 |
| August 03, 2026 | 100.31 |
| July 31, 2026 | 103.40 |
| July 30, 2026 | 107.01 |
| July 29, 2026 | 105.25 |
| July 28, 2026 | 106.16 |
| July 27, 2026 | 110.05 |
| July 24, 2026 | 110.57 |
| July 23, 2026 | 110.38 |
| July 22, 2026 | 110.34 |
| July 21, 2026 | 113.37 |
| Date | Value |
|---|---|
| July 20, 2026 | 111.06 |
| July 17, 2026 | 115.77 |
| July 16, 2026 | 113.99 |
| July 15, 2026 | 114.12 |
| July 14, 2026 | 112.08 |
| July 13, 2026 | 110.40 |
| July 10, 2026 | 119.35 |
| July 09, 2026 | 119.00 |
| July 08, 2026 | 114.16 |
| July 07, 2026 | 119.24 |
| July 06, 2026 | 114.76 |
| July 02, 2026 | 113.51 |
| July 01, 2026 | 114.20 |
| June 30, 2026 | 114.67 |
| June 29, 2026 | 109.32 |
| June 26, 2026 | 108.12 |
| June 25, 2026 | 116.46 |
| June 24, 2026 | 99.87 |
| June 23, 2026 | 98.25 |
| June 22, 2026 | 99.45 |
| June 18, 2026 | 90.43 |
| June 17, 2026 | 89.90 |
| June 16, 2026 | 87.44 |
| June 15, 2026 | 85.59 |
| June 12, 2026 | 86.20 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 86.73 |
| Oncolytics Biotech, Inc. | 0.8441 |
| Sangamo Therapeutics, Inc. | 0.16 |
| Sarepta Therapeutics, Inc. | 18.13 |
| Anixa Biosciences, Inc. | 3.62 |